IMPROVING
PATIENT AUTONOMY

Neurinnov is very pleased to  announce its implication in the AI-Hand Project, launched on last November 28th.

This EU funded project under the programme HORIZON-EIC-2022-PATHFINDEROPEN-01 will last 42 months and intends to restore hand functions in low tetraplegia through selective neural electrical stimulation.

With our partners, we are collectively committed to the success of AI-HAND, in the hope of bringing a solution to patients.

Learn more about this projet.

We are pleased to announced that Neurinnov contributes to the DREIMS european project under the program HORIZON EIC-2023-TRANSITION.

Il will last 36 months and intends to design and develop a multi-contact neural stimulator based on our selective neural stimulation technology in order to treat spinal cord injury, by combining biomaterials, pharmaceuticals, and electrical stimulation into an innovative therapeutic solution able to promote the closure of the spinal cord gap, with axonal regrowth and glial cell migration across large lesions in rodent and porcine models of spinal cord injury.

You can visit DREIMS' web site at: http://www.dreims-project.eu

We are delighted to announce that we have been awarded a €30K prize in the ‘products or services for the future’ category at the Les Inn'Ovations awards by @AD'OCC, for our implantable neurostimulator, which enables patients with complete tetraplegia to regain upper limb autonomy.

Every year, Les Inn’Ovations award recognizes some of the most innovative projects in the Occitania region of France. The awarding jury was impressed by our active implantable medical device, powered by our remotely controlled ASIC chip, which helps restore the manual grip of patients who have suffered spinal cord injury allowing them to complete everyday tasks, such as eating with a fork or drinking through a straw, giving them greater independence.